Fennec Pharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.17
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.18
|
-0.31
|
-0.13
|
-72.22%
|
|
2022-06-30
|
-0.14
|
-0.19
|
-0.05
|
-35.71%
|
|
2022-03-31
|
-0.14
|
-0.14
|
0.00
|
0.00%
|
|
2021-12-31
|
0.75
|
-0.18
|
-0.93
|
-124.00%
|
|
2021-09-30
|
-0.17
|
-0.16
|
0.01
|
5.88%
|
|
2021-06-30
|
-0.19
|
-0.15
|
0.04
|
21.05%
|
|
2021-03-31
|
-0.13
|
-0.18
|
-0.05
|
-38.46%
|
|
2020-12-31
|
-0.19
|
-0.13
|
0.06
|
31.58%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.64
|
|
2021-12-31
|
-0.67
|
|
2020-12-31
|
-0.77
|
|
2019-12-31
|
-0.64
|
|
2018-12-31
|
-0.52
|
|
2017-12-31
|
-0.48
|
|
2016-12-31
|
-0.13
|
|
2015-12-31
|
-0.06
|
|
2014-12-31
|
-0.16
|
|
2012-12-31
|
-0.62
|
|
2011-12-31
|
0.43
|
|
2010-12-31
|
-2.98
|
|
2008-12-31
|
-5.71
|
|
2007-12-31
|
-6.32
|
|
2006-12-31
|
-33.31
|
|
2004-12-31
|
-13.00
|